Novel Use of Intranasal Dexmedetomidine for Refractory Irritability in Pediatric Home Care.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of palliative medicine"
DOI: 10.1089/jpm.2022.0420
Abstract: Background: Dexmedetomidine is a selective alpha-2 agonist with sedative, analgesic, and anxiolytic properties used intravenously for procedural sedation and in the intensive care unit. The reported use of intranasal (IN) dexmedetomidine for symptom management in… read more here.
Keywords: use intranasal; refractory irritability; intranasal dexmedetomidine; care ... See more keywords